A study to assess Clinical Benefit of Crenolanib, with or without Salvage Chemotherapy, in Multiply Relapsed, FLT3 Mutant AML Patients after Prior Treatment with Gilteritinib
Latest Information Update: 12 Jan 2021
At a glance
- Drugs Crenolanib (Primary) ; Azacitidine; Cytarabine; Decitabine; Fludarabine; Granulocyte colony-stimulating factors; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 12 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology